POS1417 DO SOCIAL FACTORS IMPACT ON BIOLOGICS COSTS IN RHEUMATOID ARTHRITIS? RESULTS FROM THE MOROCCAN RBSMR REGISTRY
| العنوان: | POS1417 DO SOCIAL FACTORS IMPACT ON BIOLOGICS COSTS IN RHEUMATOID ARTHRITIS? RESULTS FROM THE MOROCCAN RBSMR REGISTRY |
|---|---|
| المؤلفون: | Fadoua Allali, O. Mkinsi, L. Achemlal, T. Harzy, A. El Maghraoui, H. Rkain, Redouane Abouqal, Hasna Hassikou, I. Hmamouchi, S. Farih, I. El Bouchti, R. Niamane, I. Linda, I. Ghozlani, Samir Ahid, Rachid Bahiri, T. Latifa, S. Fellous |
| المصدر: | Annals of the Rheumatic Diseases. 80:992.2-992 |
| بيانات النشر: | BMJ, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | business.industry, Immunology, Developing country, Disease, medicine.disease, General Biochemistry, Genetics and Molecular Biology, chemistry.chemical_compound, Indirect costs, Tocilizumab, Rheumatology, chemistry, Rheumatoid arthritis, Health insurance, medicine, Immunology and Allergy, Rituximab, business, Functional illiteracy, Demography, medicine.drug |
| الوصف: | Background:Objectives:The aim of this study was to estimate the annual direct cost of biologics in rheumatoid arthritis and to evaluate the impact of social factors on biological use and costs.Methods:Patients in the Moroccan register of biologicals (RBSMR) with available 1-year data were included. Variables related to socio-economic status, disease and biological were collected. Direct costs included prices of biologics, costs of infusions, and subcutaneous injections. Biological use and costs were compared based on social factors.Results:Our study included 197 patients (female sex of 86.8%, mean age of 52.3 ± 11 years). Patients were on one of the following therapies: Rituximab (n=132), Tocilizumab (n=37) or TNF-blockers (n=28). 44.2% of included patients have the RAMED medical assistance (health insurance scheme for the economically underprivileged). Illiteracy was noted in 45.7% of cases. Median one-year direct costs per patient were €1,665 [€1,472 - €9,879].There was no statistically significant difference in costs between men and women (p>0.05), between illiterate and literate (p>0.05). There was a statistically significant difference in costs between patients with the RAMED medical assistance scheme and other health insurances (pConclusion:This study showed that Moroccan RA patients had equal access to biologics regardless of their gender or level of education. Indeed, the insurance system influence the costs of biologics. Accessibility of those expensive treatments in a developing country seems be explained by efforts of the Moroccan ministry of health who has allocated a substantial budget for biologic DMARDs for patients with RAMED in the tertiary structures in our country.Disclosure of Interests:None declared |
| تدمد: | 1468-2060 0003-4967 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::97947a4b5e81a810d3837f404c497001 https://doi.org/10.1136/annrheumdis-2021-eular.4225 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi...........97947a4b5e81a810d3837f404c497001 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14682060 00034967 |
|---|